Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.2 to v3.6.3. This indicates a new version of the entry rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-06T16:48:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a new revision label v3.6.2. This indicates a frontend update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T09:58:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and new help/navigation items were added along with a formatting tweak to the Intervention/Treatment header and a revision note showing v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T07:56:41.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now displayed, replacing the previous Revision: v3.5.4, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-06-08T04:20:21.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4 on the page, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-05-17T10:09:39.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site or interface software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-25T18:25:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.